Literature DB >> 20227776

In-stent restenosis associated with stent malapposition: seven year optical coherence tomography findings.

Maria C Santos, Tina Lin, Peter Barlis.   

Abstract

Stent thrombosis and in-stent restenosis remain significant issues in post-coronary angioplasty care despite advances in anti-platelet therapy and stent technology. Angiographic predictors of stent failure have been proposed, but its precise mechanism has been difficult to elucidate on conventional coronary angiography and intravascular ultrasound due to the low resolution of either approach. Optical coherence tomography (OCT) as a high-resolution intracoronary imaging modality has enabled more detailed insight into the interaction between implanted stent and underlying endothelium, the evolution of unstable plaque, and the pathogenesis of late lumen loss, affirming its place as an essential tool in the modern-day cardiac catheterisation laboratory. We present a case of in-stent restenosis seven years after bare-metal stent insertion, the mechanism of which was gross stent malapposition as clearly demonstrated on OCT examination.
Copyright © 2010. Published by Elsevier Ireland Ltd.

Entities:  

Mesh:

Year:  2010        PMID: 20227776     DOI: 10.1016/j.ijcard.2010.02.068

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  3 in total

1.  Characterization of eosinophilic esophagitis murine models using optical coherence tomography.

Authors:  Aneesh Alex; Mario Noti; Elia D Tait Wojno; David Artis; Chao Zhou
Journal:  Biomed Opt Express       Date:  2014-01-27       Impact factor: 3.732

2.  FD-OCT and IVUS for detection of incomplete stent apposition in heavily calcified vessels: novel insights.

Authors:  David M Leistner; Ulf Landmesser; Georg M Fröhlich
Journal:  Open Heart       Date:  2015-12-22

Review 3.  OCT-guided Percutaneous Coronary Intervention in Bifurcation Lesions.

Authors:  Luca Longobardo; Alessio Mattesini; Serafina Valente; Carlo Di Mario
Journal:  Interv Cardiol       Date:  2019-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.